Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Nature ; 627(8003): 416-423, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38418872

RESUMO

Permanent epigenetic silencing using programmable editors equipped with transcriptional repressors holds great promise for the treatment of human diseases1-3. However, to unlock its full therapeutic potential, an experimental confirmation of durable epigenetic silencing after the delivery of transient delivery of editors in vivo is needed. To this end, here we targeted Pcsk9, a gene expressed in hepatocytes that is involved in cholesterol homeostasis. In vitro screening of different editor designs indicated that zinc-finger proteins were the best-performing DNA-binding platform for efficient silencing of mouse Pcsk9. A single administration of lipid nanoparticles loaded with the editors' mRNAs almost halved the circulating levels of PCSK9 for nearly one year in mice. Notably, Pcsk9 silencing and accompanying epigenetic repressive marks also persisted after forced liver regeneration, further corroborating the heritability of the newly installed epigenetic state. Improvements in construct design resulted in the development of an all-in-one configuration that we term evolved engineered transcriptional repressor (EvoETR). This design, which is characterized by a high specificity profile, further reduced the circulating levels of PCSK9 in mice with an efficiency comparable with that obtained through conventional gene editing, but without causing DNA breaks. Our study lays the foundation for the development of in vivo therapeutics that are based on epigenetic silencing.


Assuntos
Epigênese Genética , Epigenoma , Edição de Genes , Inativação Gênica , Animais , Camundongos , Colesterol/metabolismo , Epigênese Genética/genética , Epigenoma/genética , Edição de Genes/métodos , Hepatócitos/metabolismo , Fígado/metabolismo , Regeneração Hepática , Nanopartículas , Pró-Proteína Convertase 9/sangue , Pró-Proteína Convertase 9/deficiência , Pró-Proteína Convertase 9/genética , Proteínas Repressoras/administração & dosagem , Proteínas Repressoras/metabolismo , Dedos de Zinco
3.
J Control Release ; 370: 239-255, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38663751

RESUMO

Double pH-responsive xenopeptide carriers containing succinoyl tetraethylene pentamine (Stp) and lipo amino fatty acids (LAFs) were evaluated for CRISPR/Cas9 based genome editing. Different carrier topologies, variation of LAF/Stp ratios and LAF types as Cas9 mRNA/sgRNA polyplexes were screened in three different reporter cell lines using three different genomic targets (Pcsk9, eGFP, mdx exon 23). One U-shaped and three bundle (B2)-shaped lipo-xenopeptides exhibiting remarkable efficiencies were identified. Genome editing potency of top carriers were observed at sub-nanomolar EC50 concentrations of 0.4 nM sgRNA and 0.1 nM sgRNA for the top U-shape and top B2 carriers, respectively, even after incubation in full (≥ 90%) serum. Polyplexes co-delivering Cas9 mRNA/sgRNA with a single stranded DNA template for homology directed gene editing resulted in up to 38% conversion of eGFP to BFP in reporter cells. Top carriers were formulated as polyplexes or lipid nanoparticles (LNPs) for subsequent in vivo administration. Formulations displayed long-term physicochemical and functional stability upon storage at 4 °C. Importantly, intravenous administration of polyplexes or LNPs mediated in vivo editing of the dystrophin gene, triggering mRNA exon 23 splicing modulation in dystrophin-expressing cardiac muscle, skeletal muscle and brain tissue.


Assuntos
Sistemas CRISPR-Cas , Edição de Genes , Edição de Genes/métodos , Animais , Humanos , Nanopartículas/química , Lipídeos/química , Camundongos Endogâmicos mdx , Linhagem Celular , Camundongos Endogâmicos C57BL , Masculino , Distrofina/genética , Camundongos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA